88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib) NANJING, China , Aug. 12, 2026 /PRNewswire/ -- August 6, the NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO ® ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks CAMBRIDGE, Mass. , Aug. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company , today ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ... 2026-08-12T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research TAIPEI and SAN DIEGO , Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. ( TPEx : 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration SHANGHAI , Aug. 12, 2026 /PRNewswire/ -- Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China's ... 2026-08-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device BEIJING , Aug. 11, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic high-tech and AI ... 2026-08-11T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research Quarterly grant program provides researchers with no-cost access to Metabolon's industry-leading metabolomics platform, scientific expertise, bioinformatics tools, and data interpretation resources ... 2026-08-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging VueJect ® strengthens Bracco's integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging ... 2026-08-11T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility EAST RUTHERFORD, N.J. , Aug. 11, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the start of construction on a new research ... 2026-08-11T Biotechnology Construction/Building Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved